X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2466) 2466
Book Review (883) 883
Publication (211) 211
Book / eBook (25) 25
Book Chapter (20) 20
Magazine Article (12) 12
Newspaper Article (10) 10
Dissertation (5) 5
Conference Proceeding (3) 3
Reference (2) 2
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2199) 2199
humans (2189) 2189
female (1156) 1156
adrenal cortex hormones - therapeutic use (1149) 1149
male (1058) 1058
adult (727) 727
adrenal cortex hormones - administration & dosage (637) 637
middle aged (604) 604
corticosteroids (491) 491
asthma - drug therapy (489) 489
aged (434) 434
child (429) 429
asthma (419) 419
adolescent (402) 402
animals (362) 362
treatment outcome (356) 356
administration, inhalation (347) 347
abridged index medicus (289) 289
risk factors (272) 272
neurosciences (264) 264
adrenal cortex hormones - adverse effects (257) 257
pituitary-adrenal axis (251) 251
respiratory system (251) 251
analysis (243) 243
care and treatment (243) 243
children (240) 240
stress (238) 238
child, preschool (221) 221
adrenal cortex hormones - economics (219) 219
medicine, general & internal (217) 217
allergy (216) 216
retrospective studies (216) 216
young adult (208) 208
pharmacology & pharmacy (206) 206
drug therapy, combination (198) 198
severity of illness index (196) 196
management (187) 187
anti-asthmatic agents - therapeutic use (186) 186
quality of life (186) 186
immunology (181) 181
research (179) 179
steroids (178) 178
bronchodilator agents - therapeutic use (175) 175
therapy (170) 170
prevalence (167) 167
pregnancy (163) 163
health aspects (162) 162
endocrinology & metabolism (160) 160
drug therapy (159) 159
inhaled corticosteroids (154) 154
medicine & public health (154) 154
cost-benefit analysis (151) 151
time factors (150) 150
studies (147) 147
aged, 80 and over (146) 146
pulmonary disease, chronic obstructive - drug therapy (145) 145
pediatrics (144) 144
quality-of-life (144) 144
double-blind (142) 142
infant (142) 142
socioeconomic factors (142) 142
psychiatry (140) 140
cortisol (139) 139
risk (136) 136
mortality (131) 131
asthma - epidemiology (125) 125
article (124) 124
internal medicine (122) 122
diagnosis (121) 121
asthma - economics (117) 117
infant, newborn (115) 115
medicine (115) 115
surveys and questionnaires (115) 115
epidemiology (114) 114
inflammation (114) 114
patients (111) 111
prospective studies (111) 111
adrenergic beta-agonists - therapeutic use (109) 109
cohort studies (108) 108
immunosuppressive agents - therapeutic use (107) 107
asthma - physiopathology (106) 106
randomized controlled trials as topic (106) 106
anti-asthmatic agents - administration & dosage (105) 105
hypothalamic-pituitary-adrenal axis (105) 105
comorbidity (104) 104
adults (102) 102
disease progression (102) 102
cross-sectional studies (99) 99
practice guidelines as topic (99) 99
usage (99) 99
age factors (98) 98
chronic disease (97) 97
fluticasone propionate (97) 97
follow-up studies (97) 97
hormones (96) 96
medical research (96) 96
obstructive pulmonary-disease (96) 96
united states (94) 94
anti-bacterial agents - therapeutic use (93) 93
hypothalamo-hypophyseal system - physiopathology (93) 93
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2469) 2469
French (20) 20
German (17) 17
Spanish (10) 10
Russian (5) 5
Portuguese (3) 3
Chinese (2) 2
Italian (2) 2
Czech (1) 1
Hungarian (1) 1
Korean (1) 1
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMJ: British Medical Journal, ISSN 0959-8138, 6/2013, Volume 346, Issue 7913, pp. 20 - 22
  Now, over two decades later, new guidelines warn against the serious harms of high dose steroids. Doctors who are skeptical about the scientific basis of... 
Neurology | Spinal cord | Physicians | Committees | Standards of care | Strokes | Skepticism | Dosage | Steroids | Polls | FEATURES | STROKE | MEDICINE, GENERAL & INTERNAL | TISSUE-PLASMINOGEN ACTIVATOR | EMERGENCY PHYSICIANS | OF-INTEREST | CLAIMS | THROMBOLYSIS | SPINAL-CORD-INJURY | METHYLPREDNISOLONE | FAILURE | Conflict of Interest - economics | Spinal Cord Injuries - drug therapy | Practice Guidelines as Topic - standards | United States | Bias | Humans | Erythropoietin - adverse effects | Tissue Plasminogen Activator - economics | Periodicals as Topic - standards | Adrenal Cortex Hormones - economics | Tissue Plasminogen Activator - adverse effects | Evidence-Based Medicine - standards | Evidence-Based Medicine - trends | National Institutes of Health (U.S.) | Early Termination of Clinical Trials | Fibrinolytic Agents - adverse effects | Standard of Care - standards | Guideline Adherence - trends | Drug Industry - economics | Evidence-Based Medicine - ethics | Standard of Care - trends | Evidence-Based Medicine - economics | Erythropoietin - administration & dosage | Drug Administration Schedule | Anticholesteremic Agents - economics | Tissue Plasminogen Activator - administration & dosage | Authorship - standards | Stroke - drug therapy | Controlled Clinical Trials as Topic | Erythropoietin - economics | Trust | Anticholesteremic Agents - adverse effects | Societies, Medical - economics | Adrenal Cortex Hormones - adverse effects | Fear | Malpractice - legislation & jurisprudence | Conflict of Interest - legislation & jurisprudence | Fibrinolytic Agents - economics | Anticholesteremic Agents - administration & dosage | Fibrinolytic Agents - administration & dosage | Adrenal Cortex Hormones - administration & dosage | Conflicts of interest | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2015, Volume 136, Issue 6, pp. 1488 - 1495
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2013, Volume 8, Issue 10, pp. e75221 - e75221
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2014, Volume 135, Issue 3, pp. 682 - 688.e11
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 07/2018, Volume 48, Issue 2, pp. 114 - 126
Background: Aminosalicylates are the most frequently prescribed drugs for patients with Crohn's disease (CD), yet evidence to support their efficacy as... 
ANTIINTERFERON-GAMMA ANTIBODY | INFLAMMATORY-BOWEL-DISEASE | COLORECTAL-CANCER | DOUBLE-BLIND | HUMANIZED MONOCLONAL-ANTIBODY | PHARMACOLOGY & PHARMACY | NECROSIS-FACTOR-ALPHA | PLACEBO-CONTROLLED TRIAL | GASTROENTEROLOGY & HEPATOLOGY | 5-AMINOSALICYLIC ACID | MAINTENANCE THERAPY | HUMAN INTERLEUKIN-11 | Biological Products - economics | Crohn Disease - epidemiology | Drug Costs | Practice Patterns, Physicians' - economics | Prevalence | Crohn Disease - economics | Humans | Adrenal Cortex Hormones - economics | Mesalamine - economics | Practice Patterns, Physicians' - statistics & numerical data | Adult | Biological Products - adverse effects | Immunosuppressive Agents - economics | Immunosuppressive Agents - administration & dosage | Risk Factors | Drug Therapy, Combination - economics | Remission Induction | Adrenal Cortex Hormones - adverse effects | Crohn Disease - drug therapy | Ontario - epidemiology | Mesalamine - therapeutic use | Drug Therapy, Combination - statistics & numerical data | Immunosuppressive Agents - adverse effects | Biological Products - administration & dosage | Adrenal Cortex Hormones - administration & dosage | Drugs | Prescribing | Immunosuppressive agents | Corticoids | Medical research | Therapy | Costs | Corticosteroids | Medical services | Clinical trials | Crohn's disease | Maintenance | Regression analysis | Risk analysis | Patients | Risk factors | Crohns disease | Regression models | Adults | Cost analysis
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, pp. e0146003 - e0146003
Journal Article
14.